The Europe hyaluronic acid based dermal fillers market size was valued at over USD 820 million in 2018 and is projected to exhibit a CAGR of more than 7 % over the forecast period. Growing social media influence and increasing geriatric population are some of the factors contributing to the growth of the market.
Increase in number of aesthetic procedures being performed and rise inmedical tourismare anticipated to further boost the market. There has been a rise in number of cosmetic clinics in countries such as France, which is contributing to the growth of the Europe market. Market players are in the process of introducing advanced products to improve treatment efficiency and subsequently capturing a larger market share. In 2018, Merz launched Belotero Lips for lip enhancement and treatment of perioral lines in Germany.
With changing demographics, procedures, and products, dermatologists and physicians can customize therapies or procedures for individual patients. They opt for a combination of products for better outcomes and patient satisfaction. Botulinum toxin and hyaluronic acid dermal fillers are gaining popularity for treatment of wrinkles, owing to rising awareness about the desirable results, ease of performing these procedures, shorter hospital stays, rapid recovery with negligible incisions, wide availability of products, and minimal adverse effects.
Rapid technological advancements, product launches, and rising demand for aesthetic procedures are other major factors contributing to the growth of the market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, a total number of 227,307 nonsurgical procedures were performed in France, of which 120,156 were hyaluronic acid procedures, which is the second most preferred noninvasive procedure.
The market in Europe can be broadly studied on the basis of product into single-phase products and duplex products. Single-phase products accounted for around 58.0% share in the market in 2018 and are expected to be the largest and fastest growing segment owing to technological advancements, wide range of applications, increasing government funding for innovation, and rise in applications of implantable devices.
Hylacross technology provides a high concentration of cross-linked hyaluronic acid molecules, resulting in longevity of desirable effects. These are utilized for volumizing and correcting deeper folds, leading to higher preferability. Desired and beneficial effects produced by single-phase products are leading to increase in their preference among consumers.
The Europe hyaluronic acid based dermal fillers market has been segmented on the basis of application into wrinkle removal, lip augmentation, rhinoplasty, and others. The wrinkle removal segment held the largest market share of around 29.0% in 2018. The segment is also poised to emerge as the fastest growing application over the forecast period, registering a CAGR of 12.2%.
Hyaluronic acid fillers are gaining popularity in varied antiaging treatments. Increasing need and impulse to look young and defer the effects of aging has led to the advancement in technology, resulting in noninvasive procedures for treatment of wrinkles. Hyaluronic acid fillers are time-saving procedures that require no bandages or incisions and impose no restrictions after completion of the procedure. These act as substitutes for injectable fillers such as collagen owing to the fact that these are relatively less expensive, have a negligible risk of allergic reaction, and are more comfortable compared to injectable fillers.
In 2018, Italy dominated the overall market and is anticipated to be the fastest growing country during the forecast period. Italy has the largest geriatric population in Europe and accounts for the second largest geriatric population across the world. In 2017, Italy accounted for 21.53% of the total population with about 5 million men and 7 million women. Antiaging treatments are preferred by the elderly and middle-aged women to enhance aesthetic appeal, whereas lip and cheek augmentation procedures are preferred by women in their twenties. According to the ISAPS, about 952,830 aesthetic surgeries were performed in 2016, of which 650,995 were noninvasive procedures such as Botox and dermal fillers.
提高审美意识、快速的技术gical advancements, and shorter procedure time are among other factors driving the market in Europe. Availability of several brands provides the opportunity for physicians to choose from varied technologies. Restylane, Perfectha, Juvederm, and Belotero are some of the popular brands of hyaluronic acid dermal fillers in U.K.
Key industry contributors are Allergan, Galderma, Medicis, and Laboratoires VIVACY. Introduction of novel and advanced products and mergers and acquisitions are some of the strategic initiatives adopted by major players in the market.
For instance, in September 2018, Allergan launched its novel, dual-acting skin care product—SkinMedica LUMIVIVE System. In April 2018, the company received approval for treatment of submandibular area with CoolSculpting. This approval was expanded to include patients with a BMI of 46.2 for treating submental and submandibular areas.
Galderma and Allergan Plc are leaders in terms of strategic initiatives. In January 2019, Allergan plc established a new R&D unit in Cambridge and collaborated with famous personalities to amend the outlook of society toward aesthetic procedures. In October 2018, Galderma invested in R&D with the initiation of six new phase III and IV U.S. aesthetic clinical trials.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.09 billion |
Revenue forecast in 2026 |
USD 1.4 billion |
Growth Rate |
CAGR of 7.6% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 – 2017 |
Forecast period |
2019 – 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, country |
Country scope |
U.K.; Germany; France; Italy; Spain |
Key companies profiled |
Allergan; Galderma; Medicis; Laboratoires VIVACY |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
革命制度党cing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at regional and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the Europe hyaluronic acid based dermal fillers market report based on product, application, and country:
Product (Revenue, USD Million, 2015 - 2026)
Single-phase Products
Duplex Products
Application Outlook (Revenue, USD Million, 2015 - 2026)
Wrinkle Removal
Lip Augmentation
Rhinoplasty
Others
Country Outlook (Revenue, USD Million, 2015 - 2026)
U.K.
France
Germany
Italy
Spain
b.The Europe hyaluronic acid based dermal fillers market size was estimated at USD 979.7 million in 2019 and is expected to reach USD 1.09 billion in 2020.
b.The Europe hyaluronic acid based dermal fillers market is expected to grow at a compound annual growth rate of 7.6% from 2019 to 2026 to reach USD 1.4 billion by 2026.
b.Single-phase products accounted for around 58% share in the market in 2019. This is attributable to technological advancements, wide range of applications, and increasing government funding for innovation.
b.Some key players operating in the Europe hyaluronic acid based dermal fillers market include Allergan, Galderma, Medicis, and Laboratoires VIVACY.
b.Key factors that are driving the market growth include growing social media influence, increasing geriatric population, increase in number of aesthetic procedures being performed, and rise in medical tourism.
"The quality of research they have done for us has been excellent."